Abstract
Multiple sclerosis is characterized by inflammatory lesions dispersed throughout the central nervous system (CNS) leading to severe neurological handicap. Demyelination, axonal damage, and blood brain barrier alterations are hallmarks of this pathology, whose precise processes are not fully understood. In the experimental autoimmune encephalomyelitis (EAE) rat model that mimics many features of human multiple sclerosis, the phage display strategy was applied to select peptide ligands targeting inflammatory sites in CNS. Due to the large diversity of sequences after phage display selection, a bioinformatics procedure called “PepTeam” designed to identify peptides mimicking naturally occurring proteins was used, with the goal to predict peptides that were not background noise. We identified a circular peptide CLSTASNSC called “Ph48” as an efficient binder of inflammatory regions of EAE CNS sections including small inflammatory lesions of both white and gray matter. Tested on human brain endothelial cells hCMEC/D3, Ph48 was able to bind efficiently when these cells were activated with IL1β to mimic inflammatory conditions. The peptide is therefore a candidate for further analyses of the molecular alterations in inflammatory lesions.
Similar content being viewed by others
References
Lubetzki, C., and B. Stankoff. 2014. Demyelination in multiple sclerosis. Handbook of Clinical Neurology 122: 89–99. https://doi.org/10.1016/B978-0-444-52001-2.00004-2.
Noseworthy, J.H., C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker. 2000. Multiple sclerosis. The New England Journal of Medicine 343: 938–952. https://doi.org/10.1056/NEJM200009283431307.
Karlik, S.J., W.A. Roscoe, C. Patinote, and C. Contino-Pepin. 2012. Targeting vascular changes in lesions in multiple sclerosis and experimental autoimmune encephalomyelitis. Central Nervous System Agents in Medicinal Chemistry 12: 7–14.
Solomon, A.J., R. Watts, B.E. Dewey, and D.S. Reich. 2017. MRI evaluation of thalamic volume differentiates MS from common mimics. Neurology(R) Neuroimmunology & Neuroinflammation 4: e387. https://doi.org/10.1212/NXI.0000000000000387.
Azevedo, C.J., E. Overton, S. Khadka, J. Buckley, S. Liu, M. Sampat, O. Kantarci, et al. 2015. Early CNS neurodegeneration in radiologically isolated syndrome. Neurology(R) Neuroimmunology & Neuroinflammation 2: e102. https://doi.org/10.1212/NXI.0000000000000102.
Barkhof, F., P.A. Calabresi, D.H. Miller, and S.C. Reingold. 2009. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nature Reviews. Neurology 5: 256–266. https://doi.org/10.1038/nrneurol.2009.41.
Filippi, M., A. Charil, M. Rovaris, M. Absinta, and M. Assunta Rocca. 2014. Insights from magnetic resonance imaging. Handbook of Clinical Neurology 122: 115–149. https://doi.org/10.1016/B978-0-444-52001-2.00006-6.
Stoll, G., and M. Bendszus. 2009. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 158: 1151–1160. https://doi.org/10.1016/j.neuroscience.2008.06.045.
Tourdias, T., S. Roggerone, M. Filippi, M. Kanagaki, M. Rovaris, D.H. Miller, K.G. Petry, et al. 2012. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology 264: 225–233. https://doi.org/10.1148/radiol.12111416.
Boven, L.A., M. Van Meurs, M. Van Zwam, A. Wierenga-Wolf, R.Q. Hintzen, R.G. Boot, J.M. Aerts, S. Amor, E.E. Nieuwenhuis, and J.D. Laman. 2006. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain: A Journal of Neurology 129: 517–526. https://doi.org/10.1093/brain/awh707.
Broholm, H., B. Andersen, B. Wanscher, J.L. Frederiksen, I. Rubin, B. Pakkenberg, H.B.W. Larsson, and M. Lauritzen. 2004. Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurologica Scandinavica 109: 261–269.
Lucchinetti, C.F., R.H. Gavrilova, I. Metz, J.E. Parisi, B.W. Scheithauer, S. Weigand, K. Thomsen, et al. 2008. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain: A Journal of Neurology 131: 1759–1775. https://doi.org/10.1093/brain/awn098.
Trebst, C., F. König, R. Ransohoff, W. Brück, and M. Stangel. 2008. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions. Multiple Sclerosis (Houndmills, Basingstoke, England) 14: 728–733. https://doi.org/10.1177/1352458508089359.
Berger, C., P. Hiestand, D. Kindler-Baumann, M. Rudin, and M. Rausch. 2006. Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage. NMR in Biomedicine 19: 101–107. https://doi.org/10.1002/nbm.1007.
Tommasin, S., C. Giannì, L. De Giglio, and P. Pantano. 2017. Neuroimaging techniques to assess inflammation in multiple sclerosis. Neuroscience. https://doi.org/10.1016/j.neuroscience.2017.07.055.
Dousset, V., B. Brochet, M.S.A. Deloire, L. Lagoarde, B. Barroso, J.-M. Caille, and K.G. Petry. 2006. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR. American Journal of Neuroradiology 27: 1000–1005.
Vellinga, M.M., R.D. Oude Engberink, A. Seewann, P.J.W. Pouwels, M.P. Wattjes, S.M.A. van der Pol, C. Pering, et al. 2008. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain: A Journal of Neurology 131: 800–807. https://doi.org/10.1093/brain/awn009.
Engelhardt, B. 2008. Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines. Journal of the Neurological Sciences 274: 23–26. https://doi.org/10.1016/j.jns.2008.05.019.
Absinta, M., G. Nair, P. Sati, I.C.M. Cortese, M. Filippi, and D.S. Reich. 2015. Direct MRI detection of impending plaque development in multiple sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation 2: e145. https://doi.org/10.1212/NXI.0000000000000145.
Cramer, S.P., H. Simonsen, J.L. Frederiksen, E. Rostrup, and H.B.W. Larsson. 2014. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. NeuroImage. Clinical 4: 182–189. https://doi.org/10.1016/j.nicl.2013.12.001.
Kidd, D., F. Barkhof, R. McConnell, P.R. Algra, I.V. Allen, and T. Revesz. 1999. Cortical lesions in multiple sclerosis. Brain: A Journal of Neurology 122 (Pt 1): 17–26.
Parisi, L., M.A. Rocca, F. Mattioli, G.C. Riccitelli, R. Capra, C. Stampatori, F. Bellomi, and M. Filippi. 2014. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis. Journal of Neurology 261: 1715–1725. https://doi.org/10.1007/s00415-014-7409-5.
Smith, G.P. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (New York, N.Y.) 228: 1315–1317.
Deutscher, S.L. 2010. Phage display in molecular imaging and diagnosis of cancer. Chemical Reviews 110: 3196–3211. https://doi.org/10.1021/cr900317f.
Rakonjac, J., N.J. Bennett, J. Spagnuolo, D. Gagic, and M. Russel. 2011. Filamentous bacteriophage: biology, phage display and nanotechnology applications. Current Issues in Molecular Biology 13: 51–76.
Arap, W., M.G. Kolonin, M. Trepel, J. Lahdenranta, M. Cardó-Vila, R.J. Giordano, P.J. Mintz, et al. 2002. Steps toward mapping the human vasculature by phage display. Nature Medicine 8: 121–127. https://doi.org/10.1038/nm0202-121.
Pasqualini, R., and E. Ruoslahti. 1996. Organ targeting in vivo using phage display peptide libraries. Nature 380: 364–366. https://doi.org/10.1038/380364a0.
van Rooy, I., S. Cakir-Tascioglu, P.-O. Couraud, I.A. Romero, B. Weksler, G. Storm, W.E. Hennink, R.M. Schiffelers, and E. Mastrobattista. 2010. Identification of peptide ligands for targeting to the blood-brain barrier. Pharmaceutical Research 27: 673–682. https://doi.org/10.1007/s11095-010-0053-6.
Weksler, B.B., E.A. Subileau, N. Perrière, P. Charneau, K. Holloway, M. Leveque, H. Tricoire-Leignel, et al. 2005. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 19: 1872–1874. https://doi.org/10.1096/fj.04-3458fje.
Ransohoff, Richard M. 2012. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nature Neuroscience 15: 1074–1077. https://doi.org/10.1038/nn.3168.
Boullerne, A.I., J.J. Rodriguez, T. Touil, B. Brochet, S. Schmidt, N.D. Abrous, M. Le Moal, et al. 2002. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 22: 123–132.
Coisne, C., L. Dehouck, C. Faveeuw, Y. Delplace, F. Miller, C. Landry, C. Morissette, et al. 2005. Mouse syngenic in vitro blood-brain barrier model: A new tool to examine inflammatory events in cerebral endothelium. Laboratory Investigation; a Journal of Technical Methods and Pathology 85: 734–746. https://doi.org/10.1038/labinvest.3700281.
Kolb, G., and C. Boiziau. 2005. Selection by phage display of peptides targeting the HIV-1 TAR element. RNA Biology 2: 28–33.
Weksler, B., I.A. Romero, and P.-O. Couraud. 2013. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids and barriers of the CNS 10: 16. https://doi.org/10.1186/2045-8118-10-16.
Liebner, S., M. Corada, T. Bangsow, J. Babbage, A. Taddei, C.J. Czupalla, M. Reis, et al. 2008. Wnt/beta-catenin signaling controls development of the blood-brain barrier. The Journal of Cell Biology 183: 409–417. https://doi.org/10.1083/jcb.200806024.
Ramirez, S.H., S. Fan, M. Zhang, A. Papugani, N. Reichenbach, H. Dykstra, A.J. Mercer, R.F. Tuma, and Y. Persidsky. 2010. Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells. The American Journal of Pathology 176: 881–892. https://doi.org/10.2353/ajpath.2010.090671.
Hillyer, P., E. Mordelet, G. Flynn, and D. Male. 2003. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clinical and Experimental Immunology 134: 431–441.
Vargas-Sanchez, K., A. Vekris, and K.G. Petry. 2016. DNA subtraction of in vivo selected phage repertoires for efficient peptide pathology biomarker identification in neuroinflammation multiple sclerosis model. Biomarker Insights 11: 19–29. https://doi.org/10.4137/BMI.S32188.
Kolonin, M.G., J. Sun, K.-A. Do, C.I. Vidal, Y. Ji, K.A. Baggerly, R. Pasqualini, and W. Arap. 2006. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 20: 979–981. https://doi.org/10.1096/fj.05-5186fje.
Liang, X., H. Qin, L. Bo, D. McBride, H. Bian, P. Spagnoli, C. Di, J. Tang, and J.H. Zhang. 2014. Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats. Stroke 45: 3048–3054. https://doi.org/10.1161/STROKEAHA.114.006092.
Ouchi, N., Y. Asaumi, K. Ohashi, A. Higuchi, S. Sono-Romanelli, Y. Oshima, and K. Walsh. 2010. DIP2A functions as a FSTL1 receptor. The Journal of Biological Chemistry 285: 7127–7134. https://doi.org/10.1074/jbc.M109.069468.
Zhang, L., H.A. Mabwi, N.J. Palange, R. Jia, J. Ma, F.B. Bah, R.K. Sah, et al. 2015. Expression patterns and potential biological roles of Dip2a. PLoS One 10: e0143284. https://doi.org/10.1371/journal.pone.0143284.
Jiao, J., M. Gao, H. Zhang, N. Wang, Z. Xiao, K. Liu, M. Yang, K. Wang, and X. Xiao. 2014. Identification of potential biomarkers by serum proteomics analysis in rats with sepsis. Shock (Augusta, Ga.) 42: 75–81. https://doi.org/10.1097/SHK.0000000000000173.
Matthews, K.W., S.L. Mueller-Ortiz, and R.A. Wetsel. 2004. Carboxypeptidase N: A pleiotropic regulator of inflammation. Molecular Immunology 40: 785–793.
Cattaneo, E., C. Zuccato, and M. Tartari. 2005. Normal huntingtin function: an alternative approach to Huntington’s disease. Nature Reviews. Neuroscience 6: 919–930. https://doi.org/10.1038/nrn1806.
Schultz, G.S., and A. Wysocki. 2009. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair and Regeneration: Official Publication of the Wound Healing Society [and] the European Tissue Repair Society 17: 153–162. https://doi.org/10.1111/j.1524-475X.2009.00466.x.
Duffy, S.S., J.G. Lees, and G. Moalem-Taylor. 2014. The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Multiple Sclerosis International 2014: 285245. https://doi.org/10.1155/2014/285245.
Engelhardt, B., and S. Liebner. 2014. Novel insights into the development and maintenance of the blood-brain barrier. Cell and Tissue Research 355: 687–699. https://doi.org/10.1007/s00441-014-1811-2.
Lengfeld, J., T. Cutforth, and D. Agalliu. 2014. The role of angiogenesis in the pathology of multiple sclerosis. Vascular Cell 6: 23. https://doi.org/10.1186/s13221-014-0023-6.
Pinheiro Lopez, M.A., G. Kooij, M.R. Mizee, A. Kamermans, G. Enzmann, R. Lyck, M. Schwaninger, B. Engelhardt, and H.E. de Vries. 2016. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Biochimica et Biophysica Acta 1862: 461–471. https://doi.org/10.1016/j.bbadis.2015.10.018.
Luissint, A.-C., C. Artus, F. Glacial, K. Ganeshamoorthy, and P.-O. Couraud. 2012. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids and barriers of the CNS 9: 23. https://doi.org/10.1186/2045-8118-9-23.
Gauberti, M., A. Montagne, A. Quenault, and D. Vivien. 2014. Molecular magnetic resonance imaging of brain-immune interactions. Frontiers in Cellular Neuroscience 8: 389. https://doi.org/10.3389/fncel.2014.00389.
Li, J., Q. Zhang, Z. Pang, Y. Wang, Q. Liu, L. Guo, and X. Jiang. 2012. Identification of peptide sequences that target to the brain using in vivo phage display. Amino Acids 42: 2373–2381. https://doi.org/10.1007/s00726-011-0979-y.
Smith, M.W., G. Al-Jayyoussi, and M. Gumbleton. 2012. Peptide sequences mediating tropism to intact blood-brain barrier: an in vivo biodistribution study using phage display. Peptides 38: 172–180. https://doi.org/10.1016/j.peptides.2012.06.019.
Tani, H., J.K. Osbourn, E.H. Walker, R.A. Rush, and I.A. Ferguson. 2013. A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75(NTR.). MAbs 5: 471–478. https://doi.org/10.4161/mabs.24112.
Wan, X.M., Y.P. Chen, W.R. Xu, W.J. Yang, and L.P. Wen. 2009. Identification of nose-to-brain homing peptide through phage display. Peptides 30: 343–350. https://doi.org/10.1016/j.peptides.2008.09.026.
Jones, A.R., C.C. Stutz, Y. Zhou, J.D. Marks, and E.V. Shusta. 2014. Identifying blood-brain-barrier selective single-chain antibody fragments. Biotechnology Journal 9: 664–674. https://doi.org/10.1002/biot.201300550.
Yang, M, C. Liu, M. Niu, Y. Hu, M. Guo, J. Zhang, Y. Luo, et al. 2014. Phage-display library biopanning and bioinformatic analysis yielded a high-affinity peptide to inflamed vascular endothelium both in vitro and in vivo. Journal of Controlled Release: Official Journal of the Controlled Release Society 174: 72–80. https://doi.org/10.1016/j.jconrel.2013.11.009.
Reynolds, F., N. Panneer, C.M. Tutino, W. Michael, W.R. Skrabal, C. Moskaluk, and K.A. Kelly. 2011. A functional proteomic method for biomarker discovery. PLoS One 6: e22471. https://doi.org/10.1371/journal.pone.0022471.
Laderach, D.J., L. Gentilini, F.M. Jaworski, and D. Compagno. 2013. Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers. Prostate Cancer 519436. https://doi.org/10.1155/2013/519436.
Mendez-Huergo, S.P., S.M. Maller, M.F. Farez, K. Mariño, J. Correale, and G.A. Rabinovich. 2014. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation. Cytokine & Growth Factor Reviews 25: 247–255. https://doi.org/10.1016/j.cytogfr.2014.02.003.
Sato, S., C. St-Pierre, P. Bhaumik, and J. Nieminen. 2009. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunological Reviews 230: 172–187. https://doi.org/10.1111/j.1600-065X.2009.00790.x.
Stancic, M., J. van Horssen, V.L. Thijssen, H.-J. Gabius, P. van der Valk, D. Hoekstra, and W. Baron. 2011. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathology and Applied Neurobiology 37: 654–671. https://doi.org/10.1111/j.1365-2990.2011.01184.x.
Ilarregui, J.M., D.O. Croci, G.A. Bianco, M.A. Toscano, M. Salatino, M.E. Vermeulen, J.R. Geffner, and G.A. Rabinovich. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nature Immunology 10: 981–991. https://doi.org/10.1038/ni.1772.
McAteer, M.A., N.R. Sibson, C. von Zur Muhlen, J.E. Schneider, A.S. Lowe, N. Warrick, K.M. Channon, D.C. Anthony, and R.P. Choudhury. 2007. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nature Medicine 13: 1253–1258. https://doi.org/10.1038/nm1631.
AKNOWLEDGEMENTS
This work was supported by grants from ANR-TecSan, INSERM ANR preciput, ARSEP and the Conseil Régional d’Aquitaine (France). KVS received a doctoral fellowship from the European Network Council ENC-Network. We also thank Pr P.O. Couraud (Institut Cochin, Paris, France) for the hCMEC/D3 cell line; Pr Marc Bonneu (CBMN Bordeaux, France) for the proteomic analysis; and our colleagues M.S. Deloire, N. Dubourdieu-Cassagno, F. Ottones, and A. Vekris for the technical assistance and helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted (animal experimentation permission, France 33/00055).
Rights and permissions
About this article
Cite this article
Boiziau, C., Nikolski, M., Mordelet, E. et al. A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis. Inflammation 41, 932–947 (2018). https://doi.org/10.1007/s10753-018-0748-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-018-0748-0